Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry

Background and aims: To test the agreement of a visual rating scale of medial temporal lobe atrophy (MTA) with linear and volumetric assessments, and to test its accuracy in discriminating between Alzheimer’s disease (AD) patients and controls. Methods: Participants were 28 patients with AD and 29 healthy controls. MTA was evaluated according to Scheltens’ five-point scale. Its accuracy in distinguishing AD patients from controls was evaluated as a stand-alone measure and in association with linear [width of the temporal horn (WTH)] and volumetric [hippocampal volume (HV)] measures. Results: The agreement of this visual rating scale with the other MTA measures was statistically significant (vs WTH and vs HV, p for trend <0.00005). The visual rating scale showed a good accuracy in distinguishing AD patients from controls [area under the curve (AUC) 0.89, 95% confidence interval (CI) 0.79-0.98]. Although the accuracy of the visual rating scale improved in association with linear WTH (AUC 0.91, 95% CI 0.82–0.99) and in association with HV (AUC 0.93, 95% CI 0.86–1.00), the improvement was not significant. Conclusions: The visual rating scale of MTA, easily applicable in clinical practice, shows good agreement with more demanding quantitative methods, and can discriminate AD patients from controls with good accuracy.

[1]  N. Qizilbash Evidence based dementia practice , 2002 .

[2]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[3]  G. Frisoni,et al.  Linear measures of atrophy in mild Alzheimer disease. , 1996, AJNR. American journal of neuroradiology.

[4]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[5]  J. O'Brien,et al.  Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. , 1994, Australian and New Zealand journal of medicine.

[6]  Philip Scheltens,et al.  Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry , 1999, Psychiatry Research: Neuroimaging.

[7]  H. Braak,et al.  Pathological Changes in the Parahippocampal Region in Select Non‐Alzheimer's Dementias , 2000, Annals of the New York Academy of Sciences.

[8]  B. Sahakian,et al.  Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia , 2001, Neurology.

[9]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[10]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[11]  H. Soininen,et al.  MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.

[12]  Scheltens Ph Structural neuroimaging of Alzheimer's disease and other dementias. , 2001 .

[13]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[14]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.